Selenium (+LT4) vs placebo (+LT4)
Adverse events post‐intervention Number of people reporting an adverse event before completing the intervention · participants with Hashimoto's thyroiditis.
Selenium (+LT4) showed no clear difference in proportion of participants reporting an adverse event compared with placebo (+LT4) (low certainty).
1 finding from 1 review
- RR 2.71 [0.29, 25.66]3 studies · 258 participantsLow